Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion
- PMID: 112872
- PMCID: PMC2042395
Susceptibility of the mammary gland to carcinogenesis: I Differentiation of the mammary gland as determinant of tumor incidence and type of lesion
Abstract
The influence of age and mammary gland differentiation on the incidence of tumors induced by 7,12-dimethylbenz(a)anthracene (DMBA) was studied by correlating the development of the mammary glands of 20-180-day-old, virgin Sprague-Dawley rats with the number and type of tumors induced by DMBA administered at those various ages. The number of terminal end buds (TEBs), terminal ducts (TDs), and alveolar buds (ABs)/sq mm and their DNA-labeling indices (DNA-LI) were determined. Highest density of TEB occurred when the rats were 20 days old, decreasing thereafter. DNA-LI ranged between 25.2 and 29 in TEB of rats aged 30-55 days, which was coincident with the highest incidence of carcinomas. With aging, the number of TEBs and their DNA-LI decreased and the number of TDs and ABs increased, although with a low DNA-LI, which correlated with a lower incidence of carcinomas and higher incidence of benign lesions.
Similar articles
-
Developmental stage of the rat mammary gland as determinant of its susceptibility to 7,12-dimethylbenz[a]anthracene.J Natl Cancer Inst. 1978 Dec;61(6):1439-49. J Natl Cancer Inst. 1978. PMID: 102856
-
Induction of mammary tumors in aging rats by 7,12-dimethylbenz[a]anthracene: role of DNA synthesis during carcinogenesis.J Natl Cancer Inst. 1980 Mar;64(3):519-21. J Natl Cancer Inst. 1980. PMID: 6766511
-
Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence.Am J Pathol. 1980 Aug;100(2):497-512. Am J Pathol. 1980. PMID: 6773421 Free PMC article.
-
Basis of cellular autonomy in the susceptibility to carcinogenesis.Toxicol Pathol. 1983;11(2):149-66. doi: 10.1177/019262338301100207. Toxicol Pathol. 1983. PMID: 6443045 Review.
-
From pathogenesis to hormone prevention of mammary carcinogenesis.Cancer Surv. 1986;5(3):649-70. Cancer Surv. 1986. PMID: 3107814 Review.
Cited by
-
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4. Breast Cancer Res Treat. 2019. PMID: 31165373 Free PMC article.
-
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.Cancers (Basel). 2018 May 31;10(6):172. doi: 10.3390/cancers10060172. Cancers (Basel). 2018. PMID: 29857525 Free PMC article. Review.
-
Characterization of N-ethyl-N-nitrosourea--induced mammary tumors in the rat.Am J Pathol. 1983 Feb;110(2):161-9. Am J Pathol. 1983. PMID: 6824063 Free PMC article.
-
Effect of histamine on growth and differentiation of the rat mammary gland.Agents Actions. 1994 Jun;41 Spec No:C115-7. doi: 10.1007/BF02007792. Agents Actions. 1994. PMID: 7976794
-
Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk.Front Oncol. 2017 May 26;7:110. doi: 10.3389/fonc.2017.00110. eCollection 2017. Front Oncol. 2017. PMID: 28603694 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources